{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:36:41Z","timestamp":1783741001629,"version":"3.55.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>We report a case of a 64-year-old Japanese man who developed IgG4-related pericoronary arteritis following mRNA-based COVID-19 vaccination. The patient presented with anterior chest pain and imaging revealed perivascular soft tissue thickening around the coronary arteries, along with pancreatic enlargement, enlarged prostate, and periaortitis. Laboratory tests showed markedly elevated serum IgG4 levels (1740\u00a0mg\/dl). Histopathological findings from prostate biopsy were consistent with IgG4-related disease. Notably, retrospective analysis of preserved serum samples demonstrated a sharp increase in IgG4 levels following the third BNT162b2 vaccine dose, suggesting a possible link between vaccination and disease onset. The patient responded to prednisolone, with significant clinical and radiological improvement. However, IgG4 levels rebounded during tapering, requiring additional immunosuppressive therapy with azathioprine and planned rituximab treatment. This case represents the first documented instance tracking longitudinal changes in serum IgG4 levels from prevaccination through disease onset. While a definitive causal relationship between COVID-19 vaccination and IgG4-related disease remains unproven, this case highlights the need for further investigation into the potential immunopathogenic mechanisms involved.<\/jats:p>","DOI":"10.1093\/mrcr\/rxaf039","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T10:21:58Z","timestamp":1751970118000},"source":"Crossref","is-referenced-by-count":2,"title":["A case of IgG4-related disease potentially triggered by COVID-19 vaccination: longitudinal serum IgG4 monitoring from prevaccination"],"prefix":"10.1093","volume":"9","author":[{"given":"Ryuhei","family":"Ishihara","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-5296","authenticated-orcid":false,"given":"Ryu","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kuwamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Katsushima","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kakutani","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakaba","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Public Health, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[{"name":"Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Shoji","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Shimono","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2025080410014523900_ref1","article-title":"Coronavirus (COVID-19) dashboard [19]","author":"WHO"},{"key":"2025080410014523900_ref2","doi-asserted-by":"crossref","first-page":"e069761","DOI":"10.1136\/bmj-2021-069761","article-title":"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study","volume":"376","author":"Lauring","year":"2022","journal-title":"BMJ"},{"key":"2025080410014523900_ref3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12879-023-08754-3","article-title":"Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis","volume":"24","author":"Wu","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2025080410014523900_ref4","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41467-024-50656-8","article-title":"Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study","volume":"15","author":"Jung","year":"2024","journal-title":"Nat Commun"},{"key":"2025080410014523900_ref5","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/1756-185X.14621","article-title":"New-onset retroperitoneal fibrosis following COVID-19 mRNA vaccination: coincidental or vaccine-induced phenomenon?","volume":"26","author":"Ture","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"2025080410014523900_ref6","first-page":"97","article-title":"Acute liver injury and IgG4-related autoimmune pancreatitis following mRNA-based COVID-19 vaccination","volume":"3","author":"Patel","year":"2022","journal-title":"Hepatol Forum"},{"key":"2025080410014523900_ref7","doi-asserted-by":"crossref","first-page":"e00950","DOI":"10.14309\/crj.0000000000000950","article-title":"Type 1 autoimmune pancreatitis unmasked by COVID-19 vaccine","volume":"10","author":"Becker","year":"2023","journal-title":"ACG Case Rep J"},{"key":"2025080410014523900_ref8","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1111\/bcp.15817","article-title":"An unusual occurrence of autoimmune pancreatitis after gam-Covid-Vac (Sputnik V): a case report and literature review","volume":"89","author":"Chahed","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"2025080410014523900_ref9","doi-asserted-by":"crossref","first-page":"e01026","DOI":"10.1002\/rcr2.1026","article-title":"IgG4 related pleural disease: recurrent pleural effusion after COVID-19 vaccination","volume":"10","author":"Tasnim","year":"2022","journal-title":"Respirol Case Rep"},{"key":"2025080410014523900_ref10","doi-asserted-by":"crossref","article-title":"Seronegative type I autoimmune pancreatitis with immunoglobulin G4-related disease triggered by the Pfizer-BioNTech COVID-19 vaccine","author":"Rodrigues","DOI":"10.1016\/j.gie.2022.04.130"},{"key":"2025080410014523900_ref11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2169\/internalmedicine.1125-22","article-title":"IgG4-related disease emerging after COVID-19 mRNA vaccination","volume":"62","author":"Aochi","year":"2023","journal-title":"Intern Med"},{"key":"2025080410014523900_ref12","first-page":"e56028","article-title":"IgG4-related membranous nephropathy after COVID-19 vaccination: a case report","volume":"16","author":"Mizuno","year":"2024","journal-title":"Cureus"},{"key":"2025080410014523900_ref13","doi-asserted-by":"crossref","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","article-title":"IgG4-related disease: a clinical perspective","volume":"59","author":"Maritati","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025080410014523900_ref14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol"},{"key":"2025080410014523900_ref15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.humpath.2007.10.023","article-title":"A case of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm","volume":"39","author":"Matsumoto","year":"2008","journal-title":"Hum Pathol"},{"key":"2025080410014523900_ref16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/mrcr\/rxad065","article-title":"Solitary recurrence of IgG4-related giant coronary aneurysm: case report and review of the literature focusing on treatment strategies and complications","volume":"8","author":"Kawahara","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"2025080410014523900_ref17","doi-asserted-by":"crossref","first-page":"152184","DOI":"10.1016\/j.semarthrit.2023.152184","article-title":"IgG4-related disease as a variable-vessel vasculitis: a case series of 13 patients with medium-sized coronary artery involvement","volume":"60","author":"Katz","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2025080410014523900_ref18","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.33549\/physiolres.934408","article-title":"Cough as a cause and consequence of heart dysfunction - current state of art","volume":"69","author":"Grabczak","year":"2020","journal-title":"Physiol Res"},{"key":"2025080410014523900_ref19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"2025080410014523900_ref20","doi-asserted-by":"crossref","DOI":"10.3390\/v14071415","article-title":"Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins","volume":"14","author":"Nunez-Castilla","year":"2022","journal-title":"Viruses"},{"key":"2025080410014523900_ref21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2025080410014523900_ref22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/ard-2023-224225","article-title":"T follicular helper cells and T peripheral helper cells in rheumatic and musculoskeletal diseases","volume":"82","author":"Akiyama","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025080410014523900_ref23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","article-title":"Follicular helper T cells in the pathogenesis of IgG4-related disease","volume":"57","author":"Akiyama","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025080410014523900_ref24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/25785826.2024.2407224","article-title":"The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics","volume":"48","author":"Akiyama","year":"2025","journal-title":"Immunol Med"},{"key":"2025080410014523900_ref25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2021.12.026","article-title":"SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans","volume":"185","author":"Mudd","year":"2022","journal-title":"Cell"},{"key":"2025080410014523900_ref26","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","article-title":"Pathogenicity of IgG in patients with IgG4-related disease","volume":"65","author":"Shiokawa","year":"2016","journal-title":"Gut."},{"key":"2025080410014523900_ref27","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2023","journal-title":"Sci Immunol"},{"key":"2025080410014523900_ref28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJMcibr2113694","article-title":"A possible role for anti-idiotype antibodies in SARS-CoV-2 infection and vaccination","volume":"386","author":"Murphy","year":"2022","journal-title":"N Engl J Med"},{"key":"2025080410014523900_ref29","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection","volume":"18","author":"Liu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025080410014523900_ref30","doi-asserted-by":"crossref","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025080410014523900_ref31","doi-asserted-by":"crossref","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","article-title":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats","volume":"289","author":"Igase","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025080410014523900_ref32","doi-asserted-by":"crossref","first-page":"1398028","DOI":"10.3389\/fimmu.2024.1398028","article-title":"Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies","volume":"15","author":"Bellucci","year":"2024","journal-title":"Front Immunol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxaf039\/63702197\/rxaf039.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf039\/63702197\/rxaf039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf039\/63702197\/rxaf039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T14:02:13Z","timestamp":1754316133000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxaf039\/8193398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxaf039","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rxaf039"}}